Action PAX PAXMAN AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Paxman AB

Actions

PAX

SE0009806284

Marché Fermé - Nasdaq Stockholm
Autres places de cotation
 18:00:00 28/06/2024 		Varia. 5j. Varia. 1 janv.
47 SEK +1,73% Graphique intraday de Paxman AB +4,44% +27,72%
23/05 Paxman AB (publ) nomme Karen Giddings Clakely au conseil d'administration CI
23/05 Paxman AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
MASCC/AFSOS/ISOO 2024 Annual Meeting Features Presentation of Important Preliminary Data in Cryotherapy Side-Effect Management for Safety & Efficacy of Paxman Limb Cryocompression Device
AQ
Press release from PAXMAN AB’s 2024 Annual General Meeting
AQ
PAXMAN publishes its interim report for Q1 2024
AQ
Paxman publishes the company’s annual report for 2023
AQ
The shareholders of PAXMAN AB (publ) (”the Company”) are hereby invited to attend the Annual General Meeting on Thursday 23 May 2024 at 12:00 CEST.
AQ
See Redeye's interview with CEO Richard Paxman
AQ
Record year for Paxman!
AQ
Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm
AQ
See CEO Richard Paxman presents at Redeye Life Science Day 2023 – 23 November
AQ
See Redeye's interview with CEO Richard Paxman
AQ
PAXMAN publishes its interim report for Q3 2023
AQ
Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023
AQ
PAXMAN Announces that US Centers for Medicare and Medicaid Services (CMS) continues to support scalp cooling but decreases rate for 2024
AQ
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy
AQ
See Redeye's interview with CEO Richard Paxman
AQ
PAXMAN publishes its interim report for Q2 2023
AQ
PAXMAN announces proposal for Local Coverage Determination of scalp cooling therapy
AQ
See Redeye's interview with CEO Richard Paxman
AQ
Press release from PAXMAN AB’s 2023 Annual General Meeting
AQ
PAXMAN publishes its interim report for Q1 2023
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PAX
  4. Actualités Paxman AB
  5. Communiqués